| Title |
Complement inhibitors for age‐related macular degeneration
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2014
|
| DOI | 10.1002/14651858.cd009300.pub2 |
| Pubmed ID | |
| Authors |
Michael A Williams, Gareth J McKay, Usha Chakravarthy |
| Abstract |
Given the relatively high prevalence of age-related macular degeneration (AMD) and the increased incidence of AMD as populations age, the results of trials of novel treatments are awaited with much anticipation. The complement cascade describes a series of proteolytic reactions occurring throughout the body that generate proteins with a variety of roles including the initiation and promotion of immune reactions against foreign materials or micro-organisms. The complement cascade is normally tightly regulated, but much evidence implicates complement overactivity in AMD and so it is a logical therapeutic target in the treatment of AMD. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Unknown | 147 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 18% |
| Student > Ph. D. Student | 16 | 11% |
| Researcher | 14 | 9% |
| Student > Bachelor | 11 | 7% |
| Student > Doctoral Student | 9 | 6% |
| Other | 19 | 13% |
| Unknown | 52 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 26% |
| Nursing and Health Professions | 14 | 9% |
| Agricultural and Biological Sciences | 8 | 5% |
| Psychology | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Other | 19 | 13% |
| Unknown | 54 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2014.
All research outputs
#20,830,692
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#12,261
of 13,156 outputs
Outputs of similar age
#256,938
of 337,987 outputs
Outputs of similar age from Cochrane database of systematic reviews
#241
of 252 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 337,987 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 252 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.